FIELD: medicine.
SUBSTANCE: present invention relates to immunology. Disclosed is a method for producing the immunomodulatory monoclonal T-cell receptor against cancer (ImmTAC).
EFFECT: present invention can find further application in producing heterologous secretory proteins in bacteria.
20 cl, 88 dwg, 7 tbl, 8 ex
Authors
Dates
2020-12-25—Published
2015-11-05—Filed